NCT01892904View on ClinicalTrials.gov

Comparative Study of BAY86-5300 With a Flexible Extended Regimen for Dysmenorrhea

PHASE3CompletedINTERVENTIONAL

Enrollment

216

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

August 31, 2015

Conditions

Dysmenorrhea

Interventions

DRUG

EE20/DRSP(BAY86-5300)

One tablet \[0.02 mg of ethinylestradiol (β-CDC) and 3 mg of drospirenone\] / day

Trial Locations (8)

270-2267

Matsudo

530-0013

Osaka

542-0086

Osaka

192-0046

Hachiōji

108-0071

Minato

157-0066

Setagaya-ku

167-0051

Suginami-ku

171-0021

Toshima-ku

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY

NCT01892904 - Comparative Study of BAY86-5300 With a Flexible Extended Regimen for Dysmenorrhea | Biotech Hunter | Biotech Hunter